Evidence map›Paper›PMID 34466345›Full record

ArticleIntractable & rare diseases research2021

Mediastinal lymph node metastasis as a single expression of disease relapse in Ewing's sarcoma: multidisciplinary approach of two consecutive cases.

Filippo Tommaso Gallina, Virginia Ferraresi, Alessio Annovazzi, Sabrina Vari, Paolo Visca, Daniele Forcella, Daniela Assisi, Enrico Melis, Francesco Facciolo

Abstract readCase Reports
In one paragraph

Article in Intractable & rare diseases research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Filippo Tommaso GallinaDepartment of Thoracic Surgery, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Virginia FerraresiDepartment of Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Alessio AnnovazziNuclear Medicine Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Sabrina VariDepartment of Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Paolo ViscaPathology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Daniele ForcellaDepartment of Thoracic Surgery, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Daniela AssisiDigestive Endoscopy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Enrico MelisDepartment of Thoracic Surgery, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Francesco FaccioloDepartment of Thoracic Surgery, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ewing's sarcoma of the bone is a rare, highly aggressive tumor that typically affects children and young adults. Progress in the treatment of Ewing's sarcoma has improved survival from about 10%, before the introduction of chemotherapy, to about 75% today for patients with localized tumors. On the contrary, metastatic disease still has a poor prognosis, and a multidisciplinary approach is essential to improve the outcome. Molecular techniques and new imaging modalities are affecting the diagnosis and classification of patients with Ewing's sarcoma. The most frequent sites of metastases in Ewing's sarcoma include lungs, bones and bone marrow. Lymph nodes are a rare site of metastatic spread, particularly in the mediastinum. In this report, we present two consecutive cases of patients with Ewing's Sarcoma, diagnosed, and treated at our institute. We focused particularly on the rarity of the atypical presentation of the disease and on the synergistic strategy to adopt as a model of networking in treating patients with rare diseases.

Indexed as

EBUSEUSEwing's sarcomamediastinal lymphnodesmediastinum

Identifiers

PMID34466345
PMCPMC8397818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.